Early-onset Parkinson disease
Gene: LRRK2
DEFINITIVE gene-disease association on ClinGen - https://search.clinicalgenome.org/CCID:005305
"The mechanism of pathogenicity appears to be gain-of-function (GOF) with augmented kinase activity (PMID: 16269541). The gain-of-function mechanism is also underlined by the lack of Parkinson´s disease in carriers of truncating variants."Created: 9 Apr 2024, 4:49 a.m. | Last Modified: 9 Apr 2024, 4:49 a.m.
Panel Version: 0.295
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Parkinson disease (MONDO:0005180)
Publications
Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
This is a well-established Parkinson's disease gene.Created: 25 Aug 2023, 1:42 a.m. | Last Modified: 25 Aug 2023, 1:42 a.m.
Panel Version: 0.243
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
autosomal dominant Parkinson disease 8 MONDO:0011764; obsolete hereditary late onset Parkinson disease MONDO:0018466; Parkinson disease MONDO:0005180
Publications
Mode of inheritance for gene: LRRK2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
gene: LRRK2 was added gene: LRRK2 was added to Early onset Parkinson disease_MelbourneGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: LRRK2 was set to Unknown